Company Profile
CF PharmTech provides research and development, production, and sale of respiratory drugs and other related medical products in China. It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray.
Its portfolio also includes ChangQi, a budesonide inhalation suspension solution, ChangShu, a salbutamol sulfate inhalation solution, and piezoelectric mesh nebulizer, electric nasal cleaner, BFS hypertonic and physiological seawater nasal cleansing fluid products under the ChangShu name. It also develops products for the treatment of respiratory diseases
Including allergic rhinitis, asthma, chronic obstructive pulmonary, respiratory infection, pulmonary fibrosis, pulmonary hypertension, and respiratory diseases. Additionally, it develops therapeutic products for respiratory and diseases, such as inhalation spray and aerosol, dry powder inhaler, nebulization, nasal spray products, as well as liposomes CDMO/CMO technical services. Founded in 2007, CF PharmTech, Inc. was formerly known as Suzhou CF PharmTech Co., Ltd. CF PharmTech is based in Suzhou, China.